Eric Hoopfer

Title: Eric Hoopfer: Innovator in Neurological Research

Introduction

Eric Hoopfer is a notable inventor based in Stanford, California. He has made significant contributions to the field of neurological research, particularly in the area of axon degeneration. With a total of 2 patents, his work has the potential to impact the treatment of degenerative neuropathies.

Latest Patents

Hoopfer's latest patents focus on reducing axon degeneration using proteasome inhibitors. The first patent describes a method for reducing degeneration of an axon predetermined to be subject to degenerative neuropathy in a term patient. This is achieved by contacting the axon in situ with an effective amount of a ubiquitin-proteasome system (UPS) inhibitor. The method allows for the detection of a resultant reduction in the degeneration of the axon in situ.

Career Highlights

Throughout his career, Eric Hoopfer has worked with reputable organizations such as Children's Medical Center Corporation and Leland Stanford Junior University. His experience in these institutions has contributed to his expertise in neurological research and innovation.

Collaborations

Hoopfer has collaborated with notable colleagues, including Qiwei Zhai and Zhigang He. These partnerships have furthered his research and development efforts in the field.

Conclusion

Eric Hoopfer's innovative work in reducing axon degeneration showcases his commitment to advancing neurological research. His patents and collaborations highlight the importance of continued innovation in this critical area of medicine.